5α-Reduced Glucocorticoids: A Story of Natural Selection

    September 2011 in “ Journal of Endocrinology
    Mark Nixon, Rita Upreti, Ruth Andrew
    Image
    Studysummary This study suggests that 5α-reduced glucocorticoids may have anti-inflammatory potential and could serve as biomarkers for liver inflammation in metabolic disease, with implications for drug development.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    10 / 10 results